BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 12025986)

  • 1. Having it all: national benefit equity and local payment parity in Medicare.
    Dowd B; Feldman R
    Health Aff (Millwood); 2002; 21(3):208-14. PubMed ID: 12025986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medicare Advantage update: benefits, enrollment, and payments after the ACA.
    Linehan K
    Issue Brief George Wash Univ Natl Health Policy Forum; 2013 Jul; (850):1-12. PubMed ID: 24049878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medicare and HMOs--the search for accountability.
    Kronick R
    N Engl J Med; 2009 May; 360(20):2048-50. PubMed ID: 19439739
    [No Abstract]   [Full Text] [Related]  

  • 4. Issues regarding health plan payments under Medicare and recommendations for reform.
    Dowd B; Christianson J; Feldman R; Wisner C; Klein J
    Milbank Q; 1992; 70(3):423-53. PubMed ID: 1406495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Marketplace. Will M+C be Wennberg's window of Medicare opportunity?
    Med Health; 2001 Mar; 55(11):suppl 1-2. PubMed ID: 11261371
    [No Abstract]   [Full Text] [Related]  

  • 6. Paying Medicare+Choice plans: the view from MedPAC.
    Ross MN
    Health Aff (Millwood); 2001; Suppl Web Exclusives():W90-2. PubMed ID: 11911330
    [No Abstract]   [Full Text] [Related]  

  • 7. A needed perspective on Medicare+Choice: health plans find their senior members are potent spokespeople.
    Kertesz L
    Healthplan; 1999; 40(4):38-47, 46, 49. PubMed ID: 10557736
    [No Abstract]   [Full Text] [Related]  

  • 8. Medicare+Choice: doubling or disappearing?
    Berenson RA
    Health Aff (Millwood); 2001; Suppl Web Exclusives():W65-82. PubMed ID: 11911326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The costs of decedents in the Medicare program: implications for payments to Medicare + Choice plans.
    Buntin MB; Garber AM; McClellan M; Newhouse JP
    Health Serv Res; 2004 Feb; 39(1):111-30. PubMed ID: 14965080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perspectives. ACR showdown, mega-reg comments frame crucial payment, compliance, quality issues for Medicare+Choice.
    Cunningham R
    Med Health; 1998 Oct; 52(39):suppl 1-4. PubMed ID: 10339134
    [No Abstract]   [Full Text] [Related]  

  • 11. Can managed care and competition control Medicare costs?
    Gold M
    Health Aff (Millwood); 2003; Suppl Web Exclusives():W3-176-88. PubMed ID: 14527251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medicare program; Medicare Advantage and prescription drug benefit programs. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2011 Sep; 76(170):54600-35. PubMed ID: 21894660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An examination of factors in the withdrawal of managed care plans from the Medicare+Choice program.
    Glavin MP; Tompkins CP; Wallack SS; Altman SH
    Inquiry; 2002-2003 Winter; 39(4):341-54. PubMed ID: 12638710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Payment policy and competition in the Medicare+Choice program.
    Pizer SD; Frakt AB
    Health Care Financ Rev; 2002; 24(1):83-94. PubMed ID: 12545600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Payment reduction and Medicare private fee-for-service plans.
    Frakt AB; Pizer SD; Feldman R
    Health Care Financ Rev; 2009; 30(3):15-24. PubMed ID: 19544932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Competitive bidding in Medicare Advantage: effect of benchmark changes on plan bids.
    Song Z; Landrum MB; Chernew ME
    J Health Econ; 2013 Dec; 32(6):1301-12. PubMed ID: 24308881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disenrollment from Medicare HMOs.
    Call KT; Dowd BE; Feldman R; Lurie N; McBean MA; Maciejewski M
    Am J Manag Care; 2001 Jan; 7(1):37-51. PubMed ID: 11209449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protecting payment levels under Medicare risk-based contracting.
    Brock TH
    Healthc Financ Manage; 1997 Oct; 51(10):58-62. PubMed ID: 10173965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A standardized relative resource cost model for medical care: application to cancer control programs.
    O'Keeffe-Rosetti MC; Hornbrook MC; Fishman PA; Ritzwoller DP; Keast EM; Staab J; Lafata JE; Salloum R
    J Natl Cancer Inst Monogr; 2013; 2013(46):106-16. PubMed ID: 23962514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variations in county-level costs between traditional medicare and medicare advantage have implications for premium support.
    Biles B; Casillas G; Guterman S
    Health Aff (Millwood); 2015 Jan; 34(1):56-63. PubMed ID: 25561644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.